Having identified significant phenotypic alterations in vitro attributed to bioPROTAC-mediated HuR degradation, mouse xenograft tumour models were established by using the T21RBCC-VHHHuR and VHHHuR ODIn cell lines within an in vivo setting. Here, ELAVL1 is linked to neoplasm.